companydata.dkcompanydata.dk

BIOTECHNICS DANMARK A/S: Financial statements 2023

CVR: 29822034

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

BIOTECHNICS DANMARK A/S (CVR 29822034) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,783,219 and a net result of DKK 196,677 compared with DKK 462,441 the year before. That is an increase of 19.1% compared with the year before. Equity in the 2023 report amounted to DKK 796,677. The solvency ratio was 55.2%. The company had 3 employees in the financial year.

Gross Profit
DKK 1,783,219
Profit/Loss
DKK 196,677
Equity
DKK 796,677
Total Assets
DKK 1,443,753
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-1.8M197K797K3
2022-1.5M462K755K2
2021-89K-178K293K1
2020-146K64K471K1
2019-200K126K406K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Jens Peter Hjørnholm Sørensen leaves the board of BIOTECHNICS DANMARK A/SSep 5, 2023

As of September 5, 2023, Jens Peter Hjørnholm Sørensen has left the board of directors of BIOTECHNICS DANMARK A/S.

Allan Pettersson leaves the board of BIOTECHNICS DANMARK A/SSep 5, 2023

As of September 5, 2023, Allan Pettersson has left the board of directors of BIOTECHNICS DANMARK A/S.

BIOTECHNICS DANMARK A/S: The 2022 annual report is outJul 3, 2023

BIOTECHNICS DANMARK A/S has published its annual report for 2022. Gross profit came to DKK 1,497,168, and the net result was DKK 462,441.

About BIOTECHNICS DANMARK A/S

BIOTECHNICS DANMARK A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2009. The company is registered under the industry Anden teknisk rådgivning. The management consists of Jonas Jacob Husmer. The board consists of Flemming Heegaard (chair), Jonas Jacob Husmer and Philip Broberg Falk. The company is owned by Biosystems Holding ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 2,219,527 and a net result of DKK 276,093 compared with DKK -21,609 the year before. Equity in the 2025 report amounted to DKK 854,483.

Source: annual report 2025, Danish Business Authority